Diagnosis traps for patients with acquired NLRP3 mutation

Eur J Intern Med. 2024 Jul:125:129-131. doi: 10.1016/j.ejim.2024.01.028. Epub 2024 Mar 20.

Authors

Margaux Cescato¹, Laurence Cuisset², Laurent Le Corre¹, Mathieu P Rodero¹, Sophie Georgin-Lavialle³; F-CAPS study group

Affiliations

¹ Université Paris Cité, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Paris F-75006, France.
² Université Paris Cité, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.
³ Sorbonne Université, Department of internal medicine, National reference center for autoinflammatory diseases and AA amyloidosis, Tenon Hospital, APHP, Paris, France. Electronic address: sophie.georgin-lavialle@aphp.fr.

PMID: 38514289
DOI: 10.1016/j.ejim.2024.01.028

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adult
Cryopyrin-Associated Periodic Syndromes / diagnosis
Cryopyrin-Associated Periodic Syndromes / genetics
Female
Humans
Male
Middle Aged
Mutation*
NLR Family, Pyrin Domain-Containing 3 Protein* / genetics

Substances

NLR Family, Pyrin Domain-Containing 3 Protein
NLRP3 protein, human